Navigation Links
Anthrax Vaccine Immunization Program

The Anthrax Vaccine Immunization Program (AVIP), is the name of the policy set forth by the United States government to immunize its military and specific civilian personnel with the anthrax vaccine. It began in earnest in 1997 by the Clinton administration. Thereafter it ran into a few FDA and judicial obstacles (mainly concerning the methods and viability of the vaccine manufactured by BioPort, a subsidiary of Emergent BioSolutions Inc.).

Senior Chief Petty Officer John Payhurst administers the first in a series of anthrax vaccinations to one of 6,200 sailors aboard the aircraft carrier USS John C. Stennis (CVN 74) on March 17, 1998. Stennis and its embarked Carrier Air Wing 7 are on station in the Persian Gulf in support of Operation Southern Watch, which is the U.S. and coalition enforcement of the no-fly-zone over Southern Iraq. Payhurst, from Virginia Beach, Va., is a Navy hospital corpsmen. The Stennis is homeported in Norfolk, Va. DoD photo by Petty Officer 3rd Class Mike Larson, U.S. Navy.



In 1998, the Clinton administration required the inoculation of all military members[2][3], despite the fact that the Food and Drug Administration (FDA) issued a warning letter to the anthrax vaccine manufacturer threatening to revoke its product licenses unless immediate action was taken to correct deficiencies on March 11, 1997.[4] In June 2001, the DOD halted vaccination due to non-FDA approved changes in BioPort's manufacturing process[5].

On June 28, 2002, in the wake of the 2001 anthrax attacks and leading up to the 2003 invasion of Iraq, all military personnel were required to get anthrax vaccination[6] (in addition to their other vaccinations of smallpox and other diseases and viruses like Japanese encephalitis, Pneumococcal, Tetanus, among others[7]).

While some military personnel had questions about the safety of the vaccine, it was considered a lawful order at that time, and this made refusing the vaccine at peril of the subordinate, including possible discharge (i.e., losing their job and any benefits depending on the type of discharge). This pressure, at least for the National Guard and Reserve pilots and crewmembers, became a deciding retention factor.[1]

Later that month, the DOD made it policy to include any personnel spending 15 days or more in high anthrax-risk areas, such as the Persian Gulf or the Korean peninsula.[2]

In Dec. of 2003, Judge Emmet G. Sullivan of the United States District Court in Washington ruled that the Department of Defense could not force military personnel to take the vaccine unless through a special order by the president.[3]

In October of 2004, for about 8 days in (October 20-28), anthrax vaccinations were resumed[4], but then an injunction against mandatory vaccination was filed on the basis that the BioPort Anthrax Vaccive Absorbed (AVA) was not proven to work against inhalation anthrax.[5] The ruling held that the mandatory program was illegal. The DoD was now required to either let the individual member choose under an informed consent policy, or allowed the president to bypass this requirement by executive order.[6] For military members who had started the vaccination (which usually takes build-up and booster shots), they tended to continue the vaccination program under informed consent. For those who had a choice, they usually decided against it. [7]. The government stated that they will resume the vaccination program under informed consent in April 2005.

On December 15, 2005, the FDA re-issued a Final Rule & Order[8] on the license status of the anthrax vaccine, clearing the way for mandatory vaccination reinstatement. After reviewing extensive scientific evidence and carefully considering comments from the public, the FDA again determined that the vaccine is licensed for the prevention of anthrax, regardless of the route of exposure.

On Oct. 16, 2006 the military announced intentions to resume vaccinations for select personnel again, but the vaccinations remained voluntary until further guidance by the DoD.[9] The DoD's official resumption status of the program awaited publication of service messages.[10]

On December 13, 2006, a new class-action lawsuit[11], filed on behalf of six unnamed plaintiffs, revived the legal battle over the military’s mandatory anthrax immunization program. According to court documents, the basic premise of the lawsuit is the plaintiffs’ claim that the vaccine is “unapproved for its applied/intended use.” The lawsuit says that “plaintiffs will suffer substantial and irreparable injury if they are forced to take the vaccine,” which the suit says has not been properly approved by the government, despite the Food and Drug Administration issuing its “final rule” on the vaccine on December 15, 2005. The suit also says the Defense Department has failed to follow presidential orders and federal laws that require the government to obtain informed consent before giving an unapproved and experimental vaccine to anyone.


  1. ^ "Anthrax Vaccine, GEO's Survey of Guard and Reserve Pilots and Aircrew" United States General Accounting Office Report to Congressional Requesters. Sept. 2002. GAO-02-445.
  2. ^ Pentagon shifts Anthrax vaccine to civilian uses" James Dao with Judith Miller, June 29, 2002.

    Mirrored site:

  3. ^ "Judge: U.S. Can't Force Vaccines" CBS News, Dec. 22, 2003.
  4. ^ "Pentagon Says 200,000 Who Started Anthrax-Shot Regimen Must Continue" Sandra Jontz, Stars and Stripes European Edition, October 20, 2004
  5. ^ [1] DC District Court Permanent Injunction on Summary Judgment, Oct 27, 2004
  6. ^ "Anthrax Vaccinations Halted Again" United Press International, October 28, 2004.
  7. ^ "Troops divided on getting voluntary vaccine shots." Deborah Funk, July 25, 2005 AF Times
  8. ^ Department of Health and Human Services, Food and Drug Administration.
    Docket No. 1980N-0208
    Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order.
    AGENCY: Food and Drug Administration, HHS.
    ACTION: Notice.
  9. ^ Pentagon to Resume Anthrax Inoculations." Lolita C. Baldor, Monday, October 16, 2006.
  10. ^ DoD's official anthrax vaccine immunization program website
  11. ^ "Defense Employees Set For Another Suit to Halt Mandatory Anthrax Shots." Josh White, Wednesday, December 13, 2006; Page A19.

See also

External Links


(Date:11/18/2014)... November 18, 2014 Global ... using the telehealth platform to bring quality healthcare ... this passion, GPT created Global Partnership for TeleHealth ... already existing telehealth network. GPTM focuses specifically ... overseas, and disaster relief organizations. , ...
(Date:11/18/2014)... Sorrel Sky Gallery welcomes jewelry artist and ... her beautiful, one-of-a-kind pieces. Just in time for the holidays, ... Friday, December 5 from 5 – 7:30 p.m. for the ... creations began at her grandmother’s kitchen table at a very ... She studied at the Gemological Institute of America in California ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... low-dose aspirin therapy may not have significant heart-health benefits ... study, which involved more than 14,000 Japanese people aged ... deaths or non-fatal heart attacks and strokes between people ... "It indicates that primary prevention with daily low-dose aspirin ...
(Date:11/18/2014)... HealthDay Reporter MONDAY, Nov. 17, ... that help them track how many calories they consume each ... a popular one after their doctor recommended it did not ... idea of using such apps as weight-loss tools. Some participants ... of motivation varied, the researchers noted, and they added that ...
(Date:11/17/2014)... 2014 QuickChek customers and employees demonstrated ... “Dog Tag” Promotion. In total, the New Jersey ... Warriors® in support of military families both locally and ... nonprofit dedicated to restoring a sense of self, restoring ... members and our military families. , Throughout the ...
Breaking Medicine News(10 mins):Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2Health News:Elizabeth Showers Trunk Show & Personal Appearance Hosted by Sorrel Sky Gallery 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Calorie-Tracking Apps May Not Help You Lose Weight 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 3Health News:QuickChek Gives Big Support to Hope For The Warriors One Dollar at a Time 2
... presentations on ZEVALIN(R) scheduled at American Society of Hematology ... ... Inc.,(CTI) (Nasdaq: CTIC ; MTAX) today announced it intends to ... (Ibritumomab,Tiuxetan), known as the FIT trial, for submission to the United ...
... relationship between infection outbreaks on teeth and the presence of ... which has an unknown origin. Alopecia areata starts with bald ... The disease occurs in males and females of all ages, ... , Research by professors Jos Antonio Gil Montoya and Antonio ...
... Dec. 6, 2007 to Address FDA,s Next Big Challenge, ... Information on Drugs and Devices to Physicians and the ... banned the,use of a device that repairs damaged cells ... Magnetic Inductor (PAP-IMI),because of its apparent connection to patient ...
... 26 /PRNewswire-FirstCall/ - The Westaim Corporation,announced today that it ... of its,holdings in Canadian third party asset-backed commercial paper ... proceeds of $6.0 million.,Westaim retains the right to receive ... ABCP within six months; in such event, Westaim,will receive ...
... SINGAPORE, Nov. 26 Flextronics (Nasdaq: FLEX ),today ... Tuesday,January 29, 2008., The earnings conference call, hosted ... PST to discuss the financial results,of the Company for ... earnings call will be available via the Internet and ...
... suggests , MONDAY, Nov. 26 (HealthDay News) -- Non-white women ... linked to metastatic breast cancer, according to a study looking ... women -- all with metastatic breast cancer and bone metastases ... Inventory repeatedly over one year. The test uses a scale ...
Cached Medicine News:Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 2Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 3Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 4Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 5Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 6Health News:Infection outbreaks on teeth can cause 'alopecia areata' or localized hair loss 2Health News:Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information 2Health News:Westaim reduces ABCP exposure 2Health News:Flextronics to Report Third Quarter Results 2
Other medicine definitionOther Tags